Intravitreal injection of Ozurdex(®) implant in patients with persistent diabetic macular edema, with six-month follow-up [PDF]
, 2016 AIM: To evaluate the efficacy of intravitreal dexamethasone injections in diabetic macular edema (DME). METHODS: A 700 μg slow-release intravitreal dexamethasone implant (Ozurdex®) was placed in the vitreal cavity of 17 patients (19 eyes) affected ...
Bottone, A +8 more
core +2 more sources
A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX‑EMD Study [PDF]
, 2020 Background The clinical and economic management of retinal diseases has become more complex following the introduction of new intravitreal treatments. Multicriteria decision analysis (MCDA) offers the potential to overcome the challenges associated with ...
Casado, Miguel Ángel +19 more
core +3 more sources
DIABETIC MACULAR EDEMA: A SHORT REVIEW
Pakistan Journal of Medical Sciences, 1969 Diabetic macular edema (DME), one the most prevalent causes of visual loss in industrialized countries, may be diagnosed at any stage of diabetic retinopathy. The diagnosis, treatment, and follow up of DME have become straightforward with recent developments in fundus imaging, such as optical coherence tomography.
Fatih C. Gundogan +5 more
openaire +3 more sources
Corticosteroid Treatment in Diabetic Macular Edema
Türk Oftalmoloji Dergisi, 2017 Diabetic macular edema is the most common cause of visual impairment in patients with diabetes mellitus. The pathogenesis of macular edema is complex and multifactorial.
Burcu Nurözler Tabakcı , Nurten Ünlü
doaj +1 more source
Optical coherence tomography fast versus regular macular thickness mapping in diabetic retinopathy [PDF]
, 2008 Objective: The purpose of the study was to investigate if absolute values and reproducibility of thickness maps obtained from 2 optical coherence tomography (OCT) scanning protocols, regular high-resolution and fast low-density mode, differ in patients ...
Ceklic, Lala +2 more
core +1 more source
Journal of Diabetes Research, 2020 Retinopathy is one of the most severe diabetes-related complications, and macular edema is the major cause of central vision loss in patients with diabetes mellitus.
Corina-Iuliana Suciu +2 more
semanticscholar +1 more source
Treatment chronic macular edema in Vogt-Koyanagi Harada syndrome with dexamethasone intravitreal implant: description of three case [PDF]
, 2015 Purpose: To report our experience with dexamethasone intravitreal implant (Ozurdex, DEX implant) in the chronic cystic macular edema (ME )with Vogt-Koyanagi-Harada (VKH) Syndrome. Method: A retrospective chart review of three patients with (VKH) treated
Albanese, Giorgio +5 more
core +1 more source
Ophthalmologica, 2017 Diabetic retinal disease is envisioned to become the plague of the coming decades with a steep increase of worldwide diabetes incidence followed by a substantial rise in retinal disease.
U. Schmidt-Erfurth +9 more
semanticscholar +1 more source
Integrated results from the COPERNICUS and GALILEO studies. [PDF]
, 2017 OBJECTIVES: To report on the efficacy and safety of intravitreal aflibercept in patients with macular edema secondary to central retinal vein occlusion (CRVO) in an integrated analysis of COPERNICUS and GALILEO.
Ahlers, Christiane +13 more
core +3 more sources
Replication study: Development and validation of deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs [PDF]
, 2018 Replication studies are essential for validation of new methods, and are crucial to maintain the high standards of scientific publications, and to use the results in practice.
Bongo, Lars Ailo +2 more
core +3 more sources